Más allá del receptor de dopamina: Nuevos blancos terapéuticos para tratar la esquizofrenia

Keyphrases

• Antipsychotic Effect 20%
• Atypical Antipsychotics 20%
• Challenge Study 20%
• Cholinergic Neurotransmission 20%
• Cognitive Impairment 20%
• Cognitive Symptoms 20%
• Comparative Efficacy 20%
• Corticolimbic 20%
• Dopamine D2 Receptor (DRD2) 20%
• Dopamine Receptor 100%
• Drug Challenge 20%
• Efficacy Study 20%
• GABAergic Neurotransmission 20%
• Intervention Targets 20%
• Meta-analysis 20%
• Negative Symptoms 40%
• Novel Therapeutic Targets 100%
• Old Drugs 20%
• Pathologic 20%
• Pharmacologic Interventions 20%
• Postmortem Imaging 20%
• Schizophrenia 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Antipsychotic 50%
• Atypical Antipsychotics 50%
• Cholinergic Receptor Stimulating Agent 50%
• Cognitive Defect 50%
• Dopamine Receptor 100%
• Dopamine Receptor D2 50%
• Efficacy Study 50%
• Negative Syndrome 50%
• Symptom 100%